Indication BioScience is a pharmaceutical company developing a new generation of safer and more effective lipid-lowering cardiovascular therapies. The Company's lead program, Atorva+, is a combination of two existing FDA approved drugs seeking approval for hypercholesterolemia.
| Website | http://www.indication.bio |
| Revenue | $1 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| SIC | SIC Code 80 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Indication BioScience employee's phone or email?
Indication BioScience Questions
The Indication BioScience annual revenue was $1 million in 2026.
James Cappola is the Chief Medical Officer of Indication BioScience.
2 people are employed at Indication BioScience.
Indication BioScience is based in Silverthorne, Colorado.
The NAICS codes for Indication BioScience are [3254, 325, 32].
The SIC codes for Indication BioScience are [80, 28, 283].
Top Indication BioScience Employees
-
James Cappola
Chief Medical Officer at Indication BioScience
Chapel Hill, NC, US55+ -
5+
